Preclinical toxicological assessment of levothyroxine and liothyronine Maillard impurities
Sign Up to like & getrecommendations! Published in 2022 at "Toxicology Research"
DOI: 10.1093/toxres/tfac047
Abstract: Abstract Background Following the introduction of new stability-indicating related substances methods, an unknown impurity was observed in levothyroxine (LeMI) and liothyronine (LiMI) tablets (ADVANZ PHARMA) in concentrations ≥1.0%, from 6 months of storage onwards. The… read more here.
Keywords: day; limi; liothyronine; toxicological assessment ... See more keywords